Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

VZV vaccines using gene product expressed during latency

Oct. 17, 1997

BioTransplant and Novartis expand xenotransplantation collaboration

Oct. 15, 1997

Magnetic protein conjugates from Behringwerke

Oct. 15, 1997

LXR files IDE with FDA for heart preservation solution

Oct. 14, 1997

Yoshitomi licenses immunosuppressant to Novartis

Oct. 13, 1997

Aviron updates vaccine clinical program

Oct. 10, 1997

Therapeutic Antibodies' CytoTAb enters clinical trials

Oct. 7, 1997

MOMP DNA immunization for chlamydial infections

Oct. 6, 1997

OraVax to market and distribute Evans Medical's yellow fever vaccine

Oct. 3, 1997

North American Vaccine advances with meningitis B vaccine

Oct. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...